
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5272259
[patent_doc_number] => 20090076035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED PALIPERIDONE'
[patent_app_type] => utility
[patent_app_number] => 12/208653
[patent_app_country] => US
[patent_app_date] => 2008-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3386
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076035.pdf
[firstpage_image] =>[orig_patent_app_number] => 12208653
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/208653 | DEUTERIUM-ENRICHED PALIPERIDONE | Sep 10, 2008 | Abandoned |
Array
(
[id] => 4566179
[patent_doc_number] => 07846938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety'
[patent_app_type] => utility
[patent_app_number] => 12/207833
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 40669
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12207833
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/207833 | Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety | Sep 9, 2008 | Issued |
Array
(
[id] => 5272268
[patent_doc_number] => 20090076044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY'
[patent_app_type] => utility
[patent_app_number] => 12/207994
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29329
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076044.pdf
[firstpage_image] =>[orig_patent_app_number] => 12207994
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/207994 | VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY | Sep 9, 2008 | Abandoned |
Array
(
[id] => 6536925
[patent_doc_number] => 20100204215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/677030
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11497
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204215.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677030
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677030 | Diaminophenothiazine compounds, a method for preparing same and uses thereof | Sep 4, 2008 | Issued |
Array
(
[id] => 8103979
[patent_doc_number] => 08153635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-10
[patent_title] => 'Compounds and compositions as modulators of GPR119 activity'
[patent_app_type] => utility
[patent_app_number] => 12/204600
[patent_app_country] => US
[patent_app_date] => 2008-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70040
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/153/08153635.pdf
[firstpage_image] =>[orig_patent_app_number] => 12204600
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/204600 | Compounds and compositions as modulators of GPR119 activity | Sep 3, 2008 | Issued |
Array
(
[id] => 5324267
[patent_doc_number] => 20090062257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED VARENICLINE'
[patent_app_type] => utility
[patent_app_number] => 12/198054
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3129
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062257.pdf
[firstpage_image] =>[orig_patent_app_number] => 12198054
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/198054 | DEUTERIUM-ENRICHED VARENICLINE | Aug 24, 2008 | Abandoned |
Array
(
[id] => 5279533
[patent_doc_number] => 20090131665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI'
[patent_app_type] => utility
[patent_app_number] => 12/229701
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6766
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131665.pdf
[firstpage_image] =>[orig_patent_app_number] => 12229701
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/229701 | Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI | Aug 24, 2008 | Abandoned |
Array
(
[id] => 5272266
[patent_doc_number] => 20090076042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED ERLOTINIB'
[patent_app_type] => utility
[patent_app_number] => 12/196369
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3639
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196369
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196369 | DEUTERIUM-ENRICHED ERLOTINIB | Aug 21, 2008 | Abandoned |
Array
(
[id] => 5324367
[patent_doc_number] => 20090062357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED FLUCONAZOLE'
[patent_app_type] => utility
[patent_app_number] => 12/195956
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3638
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195956
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195956 | DEUTERIUM-ENRICHED FLUCONAZOLE | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5272267
[patent_doc_number] => 20090076043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED ALFUZOSIN'
[patent_app_type] => utility
[patent_app_number] => 12/196198
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3664
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076043.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196198
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196198 | DEUTERIUM-ENRICHED ALFUZOSIN | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5324378
[patent_doc_number] => 20090062368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED SUNITINIB'
[patent_app_type] => utility
[patent_app_number] => 12/195881
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062368.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195881
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195881 | DEUTERIUM-ENRICHED SUNITINIB | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5324333
[patent_doc_number] => 20090062323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED IRINOTECAN'
[patent_app_type] => utility
[patent_app_number] => 12/195936
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3524
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062323.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195936
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195936 | DEUTERIUM-ENRICHED IRINOTECAN | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5272255
[patent_doc_number] => 20090076031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED BORTEZOMIB'
[patent_app_type] => utility
[patent_app_number] => 12/196216
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3364
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076031.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196216
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196216 | DEUTERIUM-ENRICHED BORTEZOMIB | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5324313
[patent_doc_number] => 20090062303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED ZIPRASIDONE'
[patent_app_type] => utility
[patent_app_number] => 12/195826
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5142
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062303.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195826 | DEUTERIUM-ENRICHED ZIPRASIDONE | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5324377
[patent_doc_number] => 20090062367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED ELETRIPTAN'
[patent_app_type] => utility
[patent_app_number] => 12/195581
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4773
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062367.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195581 | DEUTERIUM-ENRICHED ELETRIPTAN | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5410703
[patent_doc_number] => 20090124602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/187909
[patent_app_country] => US
[patent_app_date] => 2008-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81107
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124602.pdf
[firstpage_image] =>[orig_patent_app_number] => 12187909
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/187909 | Amino substituted pyridines as potent kinase inhibitors | Aug 6, 2008 | Issued |
Array
(
[id] => 9455466
[patent_doc_number] => 08716476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Process for the preparation of alfuzosin hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 12/671418
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5890
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671418
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671418 | Process for the preparation of alfuzosin hydrochloride | Jul 31, 2008 | Issued |
Array
(
[id] => 6320931
[patent_doc_number] => 20100196460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Integrated Photoactive Agents for Real-Time Monitoring of Hemostasis'
[patent_app_type] => utility
[patent_app_number] => 12/669497
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7186
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196460.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669497
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669497 | Integrated photoactive agents for real-time monitoring of hemostasis | Jul 30, 2008 | Issued |
Array
(
[id] => 6466382
[patent_doc_number] => 20100190779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'VIRAL POLYMERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/671780
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27730
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190779.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671780
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671780 | Viral polymerase inhibitors | Jul 30, 2008 | Issued |
Array
(
[id] => 7778549
[patent_doc_number] => 20120040997
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2012-02-16
[patent_title] => 'VINYL-ARYL DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES'
[patent_app_type] => utility
[patent_app_number] => 12/452980
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26693
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0040/20120040997.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452980
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452980 | Vinyl-aryl derivatives for inflammation and immune-related uses | Jul 30, 2008 | Issued |